HKEX: 6622
2026 Interim Report
View original source (HKEXnews)
Earlier from Zhaoke Ophthalmology
- Notification letter to registered shareholders and reply form
- Notification letter to non-registered shareholders and reply form
- Zhaoke Ophthalmology Announces 2022 Interim Results
- Zhaoke Ophthalmology: Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration